Skip to the page

Data / Form D filings / Alloy Therapeutics, Inc.

Alloy Therapeutics, Inc.: Form D filings

Alloy Therapeutics, Inc., a biotechnology company in Waltham, MA, filed 3 Form D notices with the SEC between 2021 and 2026. The latest, on April 15, 2026, reports $30 million sold of a $40 million offering to 11 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
275 SECOND AVE SUITE 200, Waltham, MA, 02451
Phone
(617) 203-7111
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1851943

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 15, 2026New notice$39,999,940$30,020,259$9,979,68111Mar 31, 2026sec.gov
Oct 3, 2022New notice$41,744,503$41,744,50313Sep 16, 2022sec.gov
Apr 2, 2021New notice$74,999,875$74,999,87517Mar 19, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jason ColomaDirector
Errik B. AndersonExecutive Officer, Director
Logan SnyderDirector
Ulrik NielsenDirector
Jason CammDirector
Alex KolicichDirector
Piotr BobrowiczExecutive Officer, Director
Anthony SunDirector
Alaa HalawaDirector
Christian KanadyDirector

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Apr 13, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Alloy Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.